Detalles de la búsqueda
1.
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma.
BMC Cancer
; 14: 511, 2014 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25015560
2.
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy.
J Transl Med
; 10: 250, 2012 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-23245659
3.
MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression.
J Biosci
; 452020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33097678
4.
O6-methylguanine-DNA Methyltransferase Promoter Methylation in Patients with Rectal Adenocarcinoma After Chemoradiotherapy Treatment: Clinical Implications
Balkan Med J
; 36(5): 283-286, 2019 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31199091
5.
Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
PLoS One
; 10(7): e0134111, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26230845
6.
MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression
J Biosci
; 2020 Sep; : 1-9
Artículo
| IMSEAR | ID: sea-214234
7.
Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: review of recent patents.
Recent Pat Anticancer Drug Discov
; 9(1): 21-34, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23676104
Resultados
1 -
7
de 7
1
Próxima >
>>